CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases

J. C. Reijneveld, D. Brandsma, W. Boogerd, J. G.M. Bonfrer, S. Kalmijn, E. E. Voest, A. Geurts-Moespot, M. C. Visser, M. J.B. Taphoorn

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)

Abstract

The authors determined the levels of vascular endothelial growth factor (VEGF) and urokinase-type plasminogen activator (uPA) in the CSF of patients with leptomeningeal metastases (LM; n = 53), cancer patients without LM (n = 18), and subjects without malignancy (n = 25). Median levels of uPA and VEGF were significantly higher in patients with LM, supporting the hypothesis that angiogenesis contributes to LM. VEGF was negatively correlated with survival in patients with LM, suggesting its use as a prognostic factor.

Original languageEnglish
Pages (from-to)1120-1122
Number of pages3
JournalNeurology
Volume65
Issue number7
DOIs
Publication statusPublished - 11 Oct 2005

Cite this